ArticleScientific reports2025
DeepATsers: a deep learning framework for one-pot SERS biosensor to detect SARS-CoV-2 virus.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- AI/ML-Assisted SERS Biosensing for Biomolecular Detection: From Direct Spectral Response to Integrated Diagnostic Systems.Biosensors · 2026Review
- Next-Generation SERS Probes: Engineering Hotspots, Intelligent Molecular Targeting, and AI-Driven Spectral Analysis for Emerging Applications.Nanomaterials (Basel, Switzerland) · 2026Review
- Machine Learning-Enabled Intelligent Analysis of Surface-Enhanced Raman Scattering: Methods, Applications, and Perspectives.Molecules (Basel, Switzerland) · 2026Review
- Overview in Machine-Learning-Assisted Sensing Techniques for Monitoring COVID-19.Micromachines · 2026Review
- Engineering Nanomaterials for Raman Bioimaging and Theranostics: Advances, Challenges, and Future Directions.ACS omega · 2025Review
- Artificial Intelligence-Assisted Nanosensors for Clinical Diagnostics: Current Advances and Future Prospects.Biosensors · 2025Review
- Deep learning-based automated detection of endometrioid endometrial carcinoma in histopathology.Frontiers in oncology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
The integration of Artificial Intelligence (AI) techniques with medical kits has revolutionized disease diagnosis, enabling rapid and accurate identification of various conditions. We developed a novel deep learning model, namely DeepATsers based on a combination of CNN and GAN to employ a one-pot SERS biosensor to rapidly detect COVID-19 infection. The model accurately identifies each SARS-CoV-2 protein (S protein, N protein, VLP protein, Streptavidin protein, and blank signal) from its experimental fingerprint-like spectral data introduced in this study. Several augmentation techniques such as EMSA, Gaussian-noise, GAN, and K-fold cross-validation, and their combinations were utilized for the SERS spectral dataset generalization and prevented model overfitting. The original experimental dataset of 126 spectra was augmented to 780 spectra that resembled the original set by using GAN with a low KL divergence value of 0.02. This significantly improves the average accuracy of protein classification from 0.6000 to 0.9750. The deep learning model deployed optimal hyperparameters and outperformed in most measurements comparing supervised machine learning methods such as RF, GBM, SVM, and KNN, both with and without augmented spectral datasets. For model training, a whole range of spectra wavenumbers ([Formula: see text] to [Formula: see text]) as well as wavenumbers ([Formula: see text] and [Formula: see text]) only for fingerprint peak spectra were employed. The former led to highly accurate 0.9750 predictions in comparison to 0.4318 for the latter one. Finally, independent experimental spectra of SARS-CoV-2 Omicron variant were used in the model verification. Thus, DeepATsers can be considered a robust, generalized, and generative deep learning framework for 1D SERS spectral datasets of SARS-CoV-2.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.